Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 561 (ZNF561) is a member of the Krueppel C2H2-type zinc finger protein family and is predicted to act as a DNA-binding transcription factor, specifically involved in the regulation of transcription by RNA polymerase II[2][5][7]. It primarily localizes to the nucleus, where it may regulate the expression of target genes by binding to specific DNA sequences. While zinc finger proteins as a family are functionally diverse, including roles in DNA recognition, transcriptional activation, and broader gene regulation, there is currently no specific evidence establishing ZNF561 as a validated therapeutic target, nor are there known interacting drugs or defined disease associations for this protein[3][2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 561 (ZNF561).